Medical News

RSS

Galmed reports net loss of $2.5 million for first quarter 2015

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral therapy for the treatment of liver diseases, today announced financial results for the three months ended March 31, 2015.

13 May 2015

Soligenix, Emergent BioSolutions sign development agreement

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that it has initiated a development agreement with Emergent BioSolutions to implement a commercially viable, scalable production technology for the RiVax drug substance protein antigen.

13 May 2015

Australian researchers discover rogue germinal centre B cells that trigger autoimmune disease

Australian researchers believe they have discovered a group of cells that trigger autoimmune disease, as well as the molecular 'trigger guard' that normally holds them in check.

13 May 2015

Case Western Reserve researchers find potential game-changer for triple-negative breast cancer

Researchers at Case Western Reserve University combined finely crafted nanoparticles with one of nature's potent disrupters to prevent the spread of triple-negative breast cancer in mouse models.

13 May 2015

Scientists discover way to regrow bone tissue using proteins produced by stem cells

Scientists have discovered a way to regrow bone tissue using the protein signals produced by stem cells. This technology could help treat victims who have experienced major trauma to a limb, like soldiers wounded in combat or casualties of a natural disaster. The new method improves on older therapies by providing a sustainable source for fresh tissue and reducing the risk of tumor formation that can arise with stem cell transplants.

13 May 2015

Catatonia may cause regression in Down syndrome patients

Down syndrome, the most common chromosomal disorder in America, can be complicated by significant deterioration in movement, speech and functioning in some adolescents and young adults. Physicians previously attributed this regression to depression or early-onset Alzheimer's, and it has not responded to treatments.

13 May 2015

Researchers develop new tool to identify common genetic anomalies in cancer

Researchers from the University of Michigan Comprehensive Cancer Center and Thermo Fisher Scientific have developed and tested a new tool that searches for the most common genetic anomalies seen in cancer. The assay demonstrates the ability to make gene sequencing easier over a large volume of samples.

13 May 2015

Research paves way for development of individualized immunotherapy for treating cancer

Mainz-based researchers have made significant advances with regard to the development of individualized immunotherapy strategies for treating cancer. They have managed to identify the relevant genetic changes or mutations associated with various types of cancer and have determined their individual blueprints.

13 May 2015

Scientists uncover mechanism behind 'tubulin code'

Driving down the highway, you encounter ever-changing signs -- speed limits, exits, food and gas options. Seeing these roadside markers may cause you to slow down, change lanes or start thinking about lunch. In a similar way, cellular structures called microtubules are tagged with a variety of chemical markers that can influence cell functions.

13 May 2015

New study discovers master switch that drives heart cell maturation process

A molecular switch that seems to be essential for embryonic heart cells to grow into more mature, adult-like heart cells has been discovered.

13 May 2015

Repetitive head injuries may accelerate aging process, increase dementia risk

Repetitive head injuries that occur during contact sports and military service may accelerate the aging process by increasing the build-up of beta-amyloid in the brain, leading to worse disease and an increased likelihood of developing dementia. In particular, boxers fared the worst among athletes and military veterans with a history of head injuries.

13 May 2015

Invectys begins INVAC-1 phase I clinical trial in cancer patients

Invectys announces today that it has initiated a phase I clinical trial of its immunotherapeutic drug candidate INVAC-1.

13 May 2015

Study evaluates VolitionRx's proprietary Nucleosomics platform in most prevalent cancers

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions, today announced that it has accelerated its large independent prospective study evaluating its proprietary Nucleosomics platform at University Hospital Bonn in Germany.

13 May 2015

Brooks Automation, BioCision recognized with ISBER’s prestigious award for CryoPod Carrier

The CryoPod Carrier, jointly developed by Brooks Automation, a global provider of automated sample storage systems for compound management and biorepositories, and BioCision, LLC, a leader in advanced biomaterial sample handling and standardization tools, has won the 2015 New Product of the Year award from the International Society for Biological and Environmental Repositories.

13 May 2015

Orthocell’s Ortho-ATI therapy improves clinical outcomes in patients with tennis elbow degeneration

Regenerative medicine company Orthocell Limited is pleased to announce positive 3-5 year data from a study of its tendon cell treatment for tennis elbow has been presented at the International Cartilage Repair Society annual scientific meeting.

13 May 2015

Researchers present new model for evaluating malaria treatment programs across multiple countries

In a study published this month in Malaria Journal, researchers from Uppsala University and other institutions present a new model for systematically evaluating new malaria treatment programs in routine conditions across multiple countries.

13 May 2015

Lighthouse Instruments announces strategic business partnership with Robert Bosch

Lighthouse Instruments, LLC, a world leader in laser test and measurement systems for pharmaceutical process monitoring, today announced a strategic business partnership with Robert Bosch, GmbH to develop and distribute a new machine series for container closure integrity (CCI) testing using Lighthouse's laser headspace analysis (HSA) technology.

13 May 2015

Medical News

Galmed reports net loss of $2.5 million for first quarter 2015

Soligenix, Emergent BioSolutions sign development agreement

Australian researchers discover rogue germinal centre B cells that trigger autoimmune disease

Case Western Reserve researchers find potential game-changer for triple-negative breast cancer

Scientists discover way to regrow bone tissue using proteins produced by stem cells

Catatonia may cause regression in Down syndrome patients

Researchers develop new tool to identify common genetic anomalies in cancer

Research paves way for development of individualized immunotherapy for treating cancer

Scientists uncover mechanism behind 'tubulin code'

New study discovers master switch that drives heart cell maturation process

Repetitive head injuries may accelerate aging process, increase dementia risk

Invectys begins INVAC-1 phase I clinical trial in cancer patients

Study evaluates VolitionRx's proprietary Nucleosomics platform in most prevalent cancers

Brooks Automation, BioCision recognized with ISBER’s prestigious award for CryoPod Carrier

Orthocell’s Ortho-ATI therapy improves clinical outcomes in patients with tennis elbow degeneration

Researchers present new model for evaluating malaria treatment programs across multiple countries

Lighthouse Instruments announces strategic business partnership with Robert Bosch

Griffith research sheds new light on cause of Chronic Fatigue Syndrome

Managing cancer at work: Johns Hopkins launches new service for all employees

Two physicians examine heart disease through a literary lens

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News